Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi ...

Fact checked by Nick Blackmer The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine ...

Vicebio Ltd ("Vicebio" or the "Company"), a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to ...

STAFF WRITERS GIPPSLANDERS are being urged to protect themselves and their loved ones against flu and respiratory syncytial ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...

With similar symptoms and rising cases during seasonal changes, here’s how to differentiate between COVID-19, flu and RSV — ...

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of the virus. A booster dose one year after the initial shot failed to do ...

Geometric mean fold rise in titers from before to 1 month postvaccination for RSV-A and RSV-B were 11.6 vs 1.1 and 12.7 vs 1.1 in the RSVpreF vs placebo group, respectively.

The Department of Public Health and Social Services encourages proactive approach to protect oneself and others from health ...

Parents are being urged to keep a close eye on sickly youngsters after a spike in RSV cases during Thailand’s rainy season.

Pre-and post-pandemic RSV-coded and RSV-confirmed rates were lowest among people younger than 64. For instance, before COVID-19, RSV-coded and RSV-confirmed rates in Denmark stood at 0.6 and 1.8 ...